Alex Zhavoronkov, PhD, is the founder and CEO of InSilico Medicine(@InSilicoMeds), a leader in next-generation artificial intelligence technologies for drug discovery, biomarker development.

e-Meet Alex at #Sachs_EHTF

More info @ https://t.co/HI7OAD4QYO #Sachs_EHTF pic.twitter.com/37NLG3xPrp

— Sachs Associates (@SachsAssociates) January 5, 2021